Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Neuro-Oncology
|
December 17, 2020
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study
Jonas E Adolph, Gudrun Fleischhack, Ruth Mikasch, et al.
Journal of Neuro-Oncology
|
February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies
Denise Obrecht, Martin Mynarek, Christian Hagel, et al.
Neuro-Oncology
|
July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors
Anthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric Medulloblastoma
Matthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Neuro-Oncology
|
December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data
Martin Mynarek, Barry Pizer, Christelle Dufour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters
André O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Nature Communications
|
July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Shweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology
|
June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial
Martin Mynarek, Anne Rossius, Anika Guiard, et al.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica
|
December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
Martin Mynarek, Denise Obrecht, Martin Sill, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Neuro-Oncology
|
December 17, 2020
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study
Jonas E Adolph, Gudrun Fleischhack, Ruth Mikasch, et al.
Journal of Neuro-Oncology
|
February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies
Denise Obrecht, Martin Mynarek, Christian Hagel, et al.
Neuro-Oncology
|
July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors
Anthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric Medulloblastoma
Matthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Neuro-Oncology
|
December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data
Martin Mynarek, Barry Pizer, Christelle Dufour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters
André O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Nature Communications
|
July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Shweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology
|
June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial
Martin Mynarek, Anne Rossius, Anika Guiard, et al.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica
|
December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
Martin Mynarek, Denise Obrecht, Martin Sill, et al.
Page
of 10